首页> 美国卫生研究院文献>Nature Public Health Emergency Collection >Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview
【2h】

Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview

机译:转基因植物中兽医用疫苗和治疗性抗体的生产:概述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

During the past two decades, antibodies, antibody derivatives and vaccines have been developed for therapeutic and diagnostic applications in human and veterinary medicine. Numerous species of dicot and monocot plants have been genetically modified to produce antibodies or vaccines, and a number of diverse transformation methods and strategies to enhance the accumulation of the pharmaceutical proteins are now available. Veterinary applications are the specific focus of this article, in particular for pathogenic viruses, bacteria and eukaryotic parasites. We focus on the advantages and remaining challenges of plant-based therapeutic proteins for veterinary applications with emphasis on expression platforms, technologies and economic considerations.
机译:在过去的二十年中,已经开发出抗体,抗体衍生物和疫苗用于人类和兽医学中的治疗和诊断应用。已经对多种双子叶植物和单子叶植物进行了基因修饰,以生产抗体或疫苗,现在可以使用多种多样的转化方法和策略来增强药物蛋白的积累。兽医的应用是本文的重点,特别是对于病原性病毒,细菌和真核寄生虫。我们专注于用于兽医应用的植物性治疗蛋白的优势和尚存的挑战,重点是表达平台,技术和经济考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号